Cargando…
Pharmacokinetics and pharmacodynamics of hydroxychloroquine in hospitalized patients with COVID-19
BACKGROUND: Hydroxychloroquine (HCQ) dosage required to reach circulating levels that inhibit SARS-Cov-2 are extrapolated from pharmacokinetic data in non-COVID-19 patients. METHODS: We performed a population-pharmacokinetic analysis from 104 consecutive COVID-19 hospitalized patients (31 in intensi...
Autores principales: | Zahr, Noël, Urien, Saik, Llopis, Benoit, Pourcher, Valérie, Paccoud, Olivier, Bleibtreu, Alexandre, Mayaux, Julien, Gandjbakhch, Estelle, Hekimian, Guillaume, Combes, Alain, Benveniste, Olivier, Saadoun, David, Allenbach, Yves, Pinna, Bruno, Cacoub, Patrice, Funck-Brentano, Christian, Salem, Joe-Elie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Société française de pharmacologie et de thérapeutique. Published by Elsevier Masson SAS.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7842207/ https://www.ncbi.nlm.nih.gov/pubmed/33558079 http://dx.doi.org/10.1016/j.therap.2021.01.056 |
Ejemplares similares
-
Evaluation of Hydroxychloroquine Blood Concentrations and Effects in Childhood-Onset Systemic Lupus Erythematosus
por: Zahr, Noël, et al.
Publicado: (2021) -
Total and Unbound Pharmacokinetics of Cefiderocol in Critically Ill Patients
por: Zahr, Noël, et al.
Publicado: (2022) -
Echocardiography and renin-aldosterone interplay as predictors of death in COVID-19
por: Salem, Joe-Elie, et al.
Publicado: (2022) -
Comparaison des caractéristiques et des pronostics des patients avec et sans cancer actif hospitalisés pour une infection à SARS-CoV-2
por: Fenioux, Charlotte, et al.
Publicado: (2021) -
RETRACTED: Chloroquine or hydroxychloroquine for
COVID-19: why might they be hazardous?
por: Funck-Brentano, Christian, et al.
Publicado: (2020)